14. August 2024 – The Federal Department of Home Affairs (FDHA) has informed the Federal Council that the transitional periods for the new requirements for in-vitro diagnostics (IVDs) under Swiss law will be extended until approx. the end of the year. The purpose of the extension is to prevent supply shortages and to ensure alignment with EU regulations, where the transitional period has also been extended. Additionally, the simplified labeling requirements for certain IVDs will be continued indefinitely to facilitate their distribution. Starting in 2026, the obligation to register medical devices and IVDs in the «Swiss Database on Medical Devices» («swissdamed»), developed by Swissmedic, will come into effect to enhance transparency and provide an overview of available products in the Swiss market.

For more information, see here.